-
Rwandans Balk at Price of Improved Cooking Stoves
A campaign to persuade people in Rwanda to buy a new improved type of cooking stove - which uses less fuel and is less smoky - hasn't succeeded, according to the stoves' manufacturers.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
How Price Discrimination is Good for Global Health (Part 1): Professor Patricia Danzon of The Wharton School discusses differential pricing in pharmaceuticals
Professor Patricia Danzon of The Wharton School, University of Pennsylvania, discusses differential pricing -- sometimes called price discrimination -- which she maintains increases utilization of medicines and, therefore, overall social welfare.
- Categories
- Education, Health Care
- Tags
- research, supply chains
-
Impact Data Goes Lean: Simple measurement tool lets company know if it’s meeting its social mission
Acumen and Grameen helped Ziqitza, an ambulance company in India, use a simple survey tool to determine if it was meeting its social mission. The project lends credence to the idea that impact measurement can be shifted from a burden to a benefit.
- Categories
- Education, Health Care, Impact Assessment
-
Amex to Crowdsource Financial-Inclusion Ideas from Academics
It's like the opposite of "Not Invented Here" Syndrome.
- Categories
- Education, Technology
-
Johnson & Johnson Announces New Grant to Harvard Medical School to Combat Drug-Resistant Tuberculosis
Johnson & Johnson today announced its affiliate Janssen Pharmaceutica NV (Janssen) has entered into a novel collaboration with Harvard Medical School to address critical gaps in the global struggle against tuberculosis (TB).
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
- Tags
- research
-
Notts company Eminate aims to improve global health with new ingredients
After achieving global success with a salt-reduction product, a Nottingham company is working on new ingredients which could improve health.
- Categories
- Education, Health Care
-
Glaxo’s Ebola Vaccine and the Rise of Tropical-Disease R&D
Financial arguments may finally be leading Big Pharma to increase its minuscule investment in research and development of new drugs for tropical diseases.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Vittana to “cease to exist as a standalone organization”: The education-focused P2P microlender will wind down in its current form, its CEO says
“One of our founding beliefs was that once we reached scale, we could do our work sustainably, without shifting costs and risk onto the students,” wrote CEO Robin Wolander in announcing Vittana’s wind-down. “But after five years ... we haven’t found a robust business model to wean ourselves off that support.”
- Categories
- Education
- Tags
- lending, microfinance
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.